Free Trial
ETR:CCAP

CORESTATE Capital (CCAP) Stock Price, News & Analysis

€0.59
-0.02 (-3.28%)
(As of 06/11/2024 ET)
Today's Range
€0.59
€0.61
50-Day Range
€0.31
€0.62
52-Week Range
€0.26
€0.80
Volume
3,833 shs
Average Volume
N/A
Market Capitalization
$20.17 million
P/E Ratio
N/A
Dividend Yield
423.73%
Price Target
N/A
CCAP stock logo

About CORESTATE Capital Stock (ETR:CCAP)

CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC.

CCAP Stock Price History

CCAP Stock News Headlines

KBW Releases a Buy Rating on Crescent Capital BDC (CCAP)
Corestate Capital Holding SA (CCAP.HA)
Corestate Capital Holding SA (CCAP.MU)
Crescent Capital BDC Inc.
Corestate Capital Holding SA CCAP
Corestate Capital Holding SA (CCAG)
Crescent Capital BDC Inc Ordinary Shares
CORESTATE Capital Holding S.A. (CCAP.F)
Crescent Capital BDC: Q2 Earnings Snapshot
See More Headlines
Receive CCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Real Estate Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
446
Year Founded
N/A

Profitability

Net Income
$-779,800,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$110.90 million
Cash Flow
€0.99 per share
Book Value
€1.16 per share

Miscellaneous

Free Float
N/A
Market Cap
$20.17 million
Optionable
Not Optionable
Beta
1.02
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Nedim Cen (Age 58)
    CEO & Member of Management Board
  • Ms. Izabela Danner
    COO, Member of the Management Board & CIO of Group Real Estate Equity Division
  • Ms. Nadja Hoppe
    Head of Corporate Finance & Sales
  • Dr. Kai Gregor Klinger
    Chief Markets Officer
  • Ms. Kathrin Aigner
    Chief Compliance Officer
  • Dr. Katharina Kneisel
    Group General Counsel
  • Mr. Philipp Ellebracht (Age 55)
    MD & Group Head of Sales
  • Ms. Felicity Ambler
    Director of Equity Raising and Investor Relations
  • Mr. Tobias Gollnest (Age 49)
    Group Head of Investment & Commercial Real Estate and MD
  • Dr. Ralf Klann
    Managing Director of Asset Management Commercial

CCAP Stock Analysis - Frequently Asked Questions

How have CCAP shares performed in 2024?

CORESTATE Capital's stock was trading at €0.45 at the start of the year. Since then, CCAP shares have increased by 31.1% and is now trading at €0.59.
View the best growth stocks for 2024 here
.

Is CORESTATE Capital a good dividend stock?

CORESTATE Capital (ETR:CCAP) pays an annual dividend of €2.50 per share and currently has a dividend yield of 14.17%. CCAP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.

What other stocks do shareholders of CORESTATE Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CORESTATE Capital investors own include Lakeland Industries (LAKE), AbbVie (ABBV), Ovintiv (OVV), SIG (SHI), American Airlines Group (AAL), Apollo Investment (AINV), Aravive (ARAV), Apollo Commercial Real Estate Finance (ARI), Berry (BRY) and 41578029 (BT.L) (BT).

This page (ETR:CCAP) was last updated on 6/12/2024 by MarketBeat.com Staff

From Our Partners